Circulating miR-34a levels are reduced in colorectal cancer

Journal of Surgical Oncology

Volumn 106, Issue 8, 2012, Pages 947-952

  Nugent, M ^a   Miller, N ^a   Kerin, M J ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

circulation; colorectal cancer; microRNA; miR 34a; tumor markers

Indexed keywords

COMPLEMENTARY DNA; MICRORNA 145; MICRORNA 21; MICRORNA 31; MICRORNA 34A; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84869501780     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23174     Document Type: Article

References (54)

1. Garcia M, Jemal A, Ward E, et al.: Global cancer facts and figures 2007: American Cancer Society, 2007.
2. Janakiram NB, Rao CV,: Molecular markers and targets for colorectal cancer prevention. Acta Pharmacol Sin 2008; 29: 1-20.
3. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
4. Rossi S, Kopetz S, Davuluri R, et al.: MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol 2010; 42: 1291-1297.
5. Li M, Marin-Muller C, Bharadwaj U, et al.: MicroRNAs: Control and loss of control in human physiology and disease. World J Surg 2009; 33: 667-684.
6. Colorectal Cancer Survival by Stage: National Cancer Intelligence Network, 2009.
7. Zlobec I, Lugli A,: Prognostic and predictive factors in colorectal cancer. J Clin Pathol 2008; 61: 561-569.
8. Duffy MJ,: Role of tumor markers in patients with solid cancers: A critical review. Eur J Intern Med 2007; 18: 175-184.
9. Iwaniki-Caron I, Di Fiore F, Roque I, et al.: Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer. J Clin Oncol 2008; 26: 3681-3686.
10. Kim HJ, Yu MH, Kim H, et al.: Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 2008; 41: 685-692.
11. Kim JY, Kim NK, Sohn SK, et al.: Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels. Ann Surg Oncol 2009; 16: 2771-2778.
12. Tan E, Gouvas N, Nicholls RJ, et al.: Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol 2009; 18: 15-24.
13. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al.: Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-2714.
14. Grady WM, Parkin RK, Mitchell PS, et al.: Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008; 27: 3880-3888.
15. Mirnezami AH, Pickard K, Zhang L, et al.: MicroRNAs: Key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol 2009; 35: 339-347.
16. Yang L, Belaguli N, Berger DH,: MicroRNA and colorectal cancer. World J Surg 2009; 33: 638-646.
17. Bartel DP,: MicroRNAs: Genomics, biogenesis, mechanism and function. Cell 2004; 116: 281-297.
18. Paranjape T, Slack FJ, Weidhaas JB,: MicroRNAs: Tools for cancer diagnostics. Gut 2009; 58: 1546-1554.
19. Cho WC,: OncomiRs: The discovery and progress of microRNAs in cancers. Mol Cancer 2007; 25: 60.
20. Faber C, Kirchner T, Hlubek F,: The impact of microRNAs on colorectal cancer. Virchows Arch 2009; 454: 359-367.
21. He L, Hannon GJ,: MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
22. Bandres E, Cubedo E, Agirre X, et al.: Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006; 5: 29.
23. Hammond SM, Caudy AA, Hannon GJ,: Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2001; 2: 110-119.
24. Bartel DP, Chen CZ,: Micromanagers of gene expression: The potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004; 5: 396-400.
25. Bandres E, Agirre X, Bitarte N, et al.: Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009; 125: 2737-2743.
26. Miska EA,: How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005; 15: 563-568.
27. Sassen S, Miska EA, Caldas C,: MicroRNA: Implications for cancer. Virchows Arch 2008; 452: 1-10.
28. Aslam MI, Taylor K, Pringle JH, et al.: MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 2009; 96: 702-710.
29. Griffiths-Jones S, Grocock RJ, van Dongen S, et al.: miRBase: MicroRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34: D140-D144.
30. Griffiths-Jones S, Saini HK, van Dongen S, et al.: miRBase: Tools for microRNA genomics. Nucleic Acids Res 2008; 36: D154-D158.
31. Lu J, Getz G, Miska EA, et al.: MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
32. Tsujiura M, Ichikawa D, Komatsu S, et al.: Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010; 102: 1174-1179.
33. Chen X, Ba Y, Ma L, et al.: Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
34. Lawrie CH, Gal S, Dunlop HM, et al.: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-675.
35. Mitchell PS, Parkin RK, Kroh EM, et al.: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
36. Resnick KE, Alder H, Hagan JP, et al.: The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112: 55-59.
37. Heneghan HM, Miller N, Lowery AJ, et al.: MicroRNAs as novel biomarkers for breast cancer. J Oncol 2009; 2009: 950201.
38. Heneghan HM, Miller N, Lowery AJ, et al.: Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010; 251: 499-505.
39. Ng EK, Chong WW, Jin H, et al.: Differential expression of microRNAs in plasma of colorectal cancer patients: A potential marker for colorectal cancer screening. Gut 2009; 58: 1375-1381.
40. Huang Z, Huang D, Ni S, et al.: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127: 118-126.
41. Cheng H, Zhang L, Cogdell D, et al.: Circulating plasma miR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS ONE 2011; 6: e17745.
42. Chang KH, Mestdagh P, Vandesompele J, et al.: MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 2010; 10: 173.
43. Chang KH, Miller N, Kheirelseid EA, et al.: MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg Oncol 2011; 37: 597-603.
44. Nolan T, Hands RE, Bustin SA,: Quantification of mRNA using real-time RT-PCR. Nat Prot 2006; 1: 1559-1582.
45. Chang TC, Wentzel EA, Kent OA, et al.: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-752.
46. Lodygin D, Tarasov V, Epanchintsev A, et al.: Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008; 7: 2591-2600.
47. Hermeking H,: The miR-34 family in cancer and apoptosis. Cell Death Differ 2010; 17: 193-199.
48. Welch C, Chen Y, Stallings RL,: MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007; 26: 5017-5022.
49. Slack FJ, Weidhaas JB,: MicroRNA in cancer prognosis. N Engl J Med 2008; 359: 2720-2722.
50. Asangani IA, Rasheed SA, Nikolova DA, et al.: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-2136.
51. Waldman SA, Terzic A,: Translating MicroRNA discovery into clinical biomarkers in cancer. JAMA 2007; 297: 1923-1925.
52. Slaby O, Svoboda M, Michalek J, et al.: MicroRNAs in colorectal cancer: Translation of molecular biology into clinical application. Mol Cancer 2009; 8: 102.
53. Bovell L, Shanmugam C, Katkoori VR, et al.: miRNAs are stable in colorectal cancer archival tissue blocks. Front Biosci (Elite Ed) 2012; 4: 1937-1940.
54. Mraz M, Malinova K, Mayer J, et al.: MicroRNA isolation and stability in stored RNA samples. Biochemical and biophysical research communications 2009; 390: 1-4.